Heterozygous FXII variant carriers protected against VTE with no risk for bleeding. In vivo validation further evaluated thrombin generation. This data further pushes FXII as a potential drug target that could prevent VTE in a safe and effective way!
https://t.co/gov8AQuABq
🚨The ISTH is accepting applications for SSC Subcommittee Co-Chairs! With openings across 21 subcommittees, this is your chance: https://t.co/YT18OZiJVJ
Want a behind-the-scenes look? In a recent Pulse episode, we talked with SSC Chair Kathleen Freson about all things SSC: https://t.co/e024kyCU8A
Please consider supporting a vital cause in Uganda. A new van is needed to reach children with hemophilia who currently suffer without care. Every contribution helps. Share and donate! https://t.co/WSFNu5nUBX
Thrilled to share the Notice of Award for my first R01 from @NIH @nih_nhlbi! Excited to continue working with co-investigators @RobertHLee8 @UNC_BRC and Alex Dregan @KingsCollegeLon. Huge thanks to everyone that supported this work @UNC_BRC and beyond.
Curious about C1 Inhibitor? 💡
Steven Grover (@StevenPGrover) presents "New insights into the role of C1 inhibitor" as an #ISTH2024 state-of-the-art talk.
Check it out - SOA 13.2, 0825, 24 June
#coagcapsule
Read the abstract here: https://t.co/3gRnJcGNKA
Looking forward to sharing updates of our groups work investigating the relationship between C1-inhibitor and VTE at the SoA session this morning in beautiful Bangkok! #ISTH2024@ISTH@UNC_BRC
🚨🚨🚨 Do you use the murine inferior vena cava stenosis model of venous thrombosis? As part of our @ISTH SSC project please consider completing this REDcap survey (open through March 31st). Look out for preliminary findings at ISTH Bangkok. Please share!
https://t.co/QM2oRRjRwo
Fantastic work by @uk_surgeon and colleagues providing mechanistic insights into the association between venous thrombosis and enhanced atherosclerosis. Great to see this published in @CircAHA. Pleased to have played even a small part. @UNC_BRC